Androgens’ ability to counteract estrogens/ER-dependent tumor growth has been observed in both normal mammary epithelium [32] and preclinical models of ER+ breast cancer [31,33,34,35,36,37,38,39,40]. This evidence concerns the gene ESR1 and breast carcinoma.